Current report filing

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFCIT (unaudited)

v3.19.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFCIT (unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 01, 2019
Jan. 01, 2018
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Balance, beginning $ (15,894,000) $ 14,291,000 $ (24,628,000) $ (15,894,000) $ 11,517,000 $ 14,291,000 $ (15,894,000) $ 14,291,000 $ 14,291,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Beneficial conversion feature relating to convertible and promissory notes payable     5,391,000 2,039,000 5,583,000 3,638,000      
Exercise of warrants     181,000 5,000          
Stock issued for cash     730,000 2,530,000   275,000      
Repurchase of common stock           (1,314,000)      
Conversion of notes payable to common stock       329,000          
Share-based compensation     438,000 536,000 955,000 710,000      
Exercise of common stock options       1,000          
Foreign currency translation effect     (9,000) 8,000 2,000 14,000 (2,000) 16,000  
Net income (loss)     (19,327,000) (14,153,000) (47,345,000) (6,097,000) (33,480,000) (53,442,000)  
Balance, ending     (37,224,000) (24,628,000) (29,288,000) 11,517,000 (37,224,000) (29,288,000) (15,894,000)
ASC 842 [Member]                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cumulative effect adjustment on adoption (29,000)     (29,000)          
ASU 2016-01 [Member]                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cumulative effect adjustment on adoption   41,400,000         41,400,000    
Common Stock [Member]                  
Balance, beginning $ 36,000 $ 35,000 $ 36,000 $ 36,000 $ 35,000 $ 35,000 $ 36,000 $ 35,000 $ 35,000
Balance, beginning (in shares) 35,558,305 34,885,506 35,947,804 35,558,305 34,910,506 34,885,506 35,558,305 34,885,506 34,885,506
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of warrants (in Shares)     50,500 500          
Stock issued for cash (in shares)     73,090 307,500   25,000      
Repurchase of common stock         $ (1,000)        
Repurchase of common stock (in shares)         (700,000)        
Conversion of notes payable to common stock (in shares)       81,332          
Exercise of common stock options (in shares)       167          
Exercise of warrants (cashless) (in shares)         8,316        
Balance, ending     $ 36,000 $ 36,000 $ 34,000 $ 35,000 $ 36,000 $ 34,000 $ 36,000
Balance, ending (in shares)     36,071,394 35,947,804 34,218,822 34,910,506 36,071,394 34,218,822 35,558,305
Additional Paid-In Capital [Member]                  
Balance, beginning $ 140,904,000 $ 113,112,000 $ 146,344,000 $ 140,904,000 $ 117,735,000 $ 113,112,000 $ 140,904,000 $ 113,112,000 $ 113,112,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Beneficial conversion feature relating to convertible and promissory notes payable     5,391,000 2,039,000 5,583,000 3,638,000      
Exercise of warrants     181,000 5,000          
Stock issued for cash     730,000 2,530,000   275,000      
Repurchase of common stock         1,000        
Conversion of notes payable to common stock       329,000          
Share-based compensation     438,000 536,000 955,000 710,000      
Exercise of common stock options       1,000          
Balance, ending     153,084,000 146,344,000 124,274,000 117,735,000 153,084,000 124,274,000 140,904,000
Accumulated Other Comprehensive Income (Loss) [Member]                  
Balance, beginning (69,000) 41,276,000 (62,000) (69,000) (72,000) 41,276,000 (69,000) 41,276,000 41,276,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Foreign currency translation effect     6,000 7,000 2,000 14,000      
Balance, ending     (56,000) (62,000) (70,000) (72,000) (56,000) (70,000) (69,000)
Accumulated Other Comprehensive Income (Loss) [Member] | ASU 2016-01 [Member]                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cumulative effect adjustment on adoption           (41,362,000)      
Treasure Stock, at cost [Member]                  
Balance, beginning         (1,314,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Repurchase of common stock           (1,314,000)      
Balance, ending         (1,314,000) (1,314,000)   (1,314,000)  
Accumulated Deficit [Member]                  
Balance, beginning (156,668,000) (140,132,000) (170,864,000) (156,668,000) (104,867,000) (140,132,000) (156,668,000) (140,132,000) (140,132,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss)     (18,639,000) (14,167,000) (47,345,000) (6,097,000)      
Balance, ending     (189,503,000) (170,864,000) (152,212,000) (104,867,000) (189,503,000) (152,212,000) (156,668,000)
Accumulated Deficit [Member] | ASC 842 [Member]                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cumulative effect adjustment on adoption       (29,000)          
Accumulated Deficit [Member] | ASU 2016-01 [Member]                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cumulative effect adjustment on adoption           41,362,000      
Total Emmaus Stockholders' Equity / Deficit [Member]                  
Balance, beginning (15,797,000) $ 14,291,000 (24,546,000) (15,797,000) 11,517,000 14,291,000 (15,797,000) 14,291,000 14,291,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Beneficial conversion feature relating to convertible and promissory notes payable     5,391,000 2,039,000 5,583,000 3,638,000      
Exercise of warrants     181,000 5,000          
Stock issued for cash     730,000 2,530,000   275,000      
Repurchase of common stock           (1,314,000)      
Conversion of notes payable to common stock       329,000          
Share-based compensation     438,000 536,000 955,000 710,000      
Exercise of common stock options       1,000          
Foreign currency translation effect     6,000 7,000 2,000 14,000      
Net income (loss)     (18,639,000) (14,167,000) (47,345,000) (6,097,000)      
Balance, ending     (36,439,000) (24,546,000) $ (29,288,000) $ 11,517,000 (36,439,000) $ (29,288,000) (15,797,000)
Total Emmaus Stockholders' Equity / Deficit [Member] | ASC 842 [Member]                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Cumulative effect adjustment on adoption       (29,000)          
Non-controlling Interests [Member]                  
Balance, beginning $ (97,000)   (82,000) (97,000)     (97,000)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Foreign currency translation effect     (15,000) 1,000          
Net income (loss)     (688,000) 14,000          
Balance, ending     $ (785,000) $ (82,000)     $ (785,000)   $ (97,000)